3,4-dehydrobrevicomin: testosterone-dependent volatile constituent of male mouse urine; structure given in first source; RN given refers to exo-isomer
ID Source | ID |
---|---|
PubMed CID | 536095 |
MeSH ID | M0121120 |
Synonym |
---|
7-ethyl-5-methyl-6,8-dioxabicyclo[3.2.1]oct-3-ene |
3,4-dehydrobrevicomin |
62255-25-8 |
6-ethyl-1-methyl-7,8-dioxabicyclo[3.2.1]oct-2-ene |
exo-7-ethyl-5-methyl-6,8-dioxabicyclo(3.2.1)oct-3-ene |
6,8-dioxabicyclo(3.2.1)oct-3-ene, 7-ethyl-5-methyl-, exo- |
3,4-dehydro-exo-brevicomin |
7-exo-ethyl-5-methyl-6,8-dioxabicyclo[3.2.1]oct-3-ene |
OTGRTVQRUOULGI-UHFFFAOYSA-N |
7-ethyl-5-methyl-6,8-dioxabicyclo[3.2.1]oct-3-ene # |
159912-77-3 |
3,4-dehydro-exo-7-ethyl-5-methyl-6,8-dioxabicyclo[3.2.1]octane |
6,8-dioxabicyclo[3.2.1]oct-3-ene, 7-ethyl-5-methyl- |
DTXSID00977829 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (33.33) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.47) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |